{"transactions":[{"id":4632443,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-01T21:23:02.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":5119,"price":2.93,"value":14998.67,"ownership":{"direct":true},"balance_after":56431,"source":{"system":"sec-edgar","filing":"0001161697-26-000225","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000225/form_4.xml","form_type":"4"}},{"id":722236,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T21:21:28.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":4.2,"value":14998.2,"ownership":{"direct":true},"balance_after":51312,"source":{"system":"sec-edgar","filing":"0001161697-26-000151","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000151/form_4.xml","form_type":"4"}},{"id":823668,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T20:48:13.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":3472,"price":4.32,"value":14999.04,"ownership":{"direct":true},"balance_after":47741,"source":{"system":"sec-edgar","filing":"0001161697-26-000084","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000084/form_4.xml","form_type":"4"}},{"id":956002,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-02T23:51:34.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2581,"price":5.81,"value":14995.61,"ownership":{"direct":true},"balance_after":44269,"source":{"system":"sec-edgar","filing":"0001161697-26-000013","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000013/form_4.xml","form_type":"4"}},{"id":1028624,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:41:06.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":3916,"price":3.83,"value":14998.28,"ownership":{"direct":true},"balance_after":41688,"source":{"system":"sec-edgar","filing":"0001161697-25-000340","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000340/form_4.xml","form_type":"4"}},{"id":1096930,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:56:36.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":4189,"price":3.58,"value":14996.62,"ownership":{"direct":true},"balance_after":37772,"source":{"system":"sec-edgar","filing":"0001161697-25-000205","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000205/form_4.xml","form_type":"4"}},{"id":1185446,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:30:38.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":5870,"price":2.56,"value":15027.2,"ownership":{"direct":true},"balance_after":33583,"source":{"system":"sec-edgar","filing":"0001161697-25-000135","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000135/form_4.xml","form_type":"4"}},{"id":1317606,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T21:29:14.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":3937,"price":3.81,"value":14999.97,"ownership":{"direct":true},"balance_after":27713,"source":{"system":"sec-edgar","filing":"0001161697-25-000022","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000022/form_4.xml","form_type":"4"}},{"id":1397518,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-01T20:06:55.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":5454,"price":2.75,"value":14998.5,"ownership":{"direct":true},"balance_after":23776,"source":{"system":"sec-edgar","filing":"0001161697-24-000411","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000411/form_4.xml","form_type":"4"}},{"id":1455670,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-12T14:42:25.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":5545,"price":2.71,"value":15026.95,"ownership":{"direct":true},"balance_after":18322,"source":{"system":"sec-edgar","filing":"0001161697-24-000310","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000310/form_4.xml","form_type":"4"}},{"id":1557150,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:13:24.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":6329,"price":2.37,"value":14999.73,"ownership":{"direct":true},"balance_after":12777,"source":{"system":"sec-edgar","filing":"0001161697-24-000174","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000174/form_4.xml","form_type":"4"}},{"id":1697434,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-02T21:54:01.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":6329,"price":2.37,"value":14999.73,"ownership":{"direct":true},"balance_after":6448,"source":{"system":"sec-edgar","filing":"0001161697-24-000013","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169724000013/form_4.xml","form_type":"4"}},{"id":1764049,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T20:05:49.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":119,"price":2.74,"value":326.06,"ownership":{"direct":true},"balance_after":119,"source":{"system":"sec-edgar","filing":"0001161697-23-000526","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169723000526/form_4.xml","form_type":"4"}},{"id":2937886,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-12-18T16:15:23.000Z","date":"2020-12-17","kind":"exercise","acquired":false,"shares":164822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 2, 2019, the Reporting Person was granted 82,411 restricted stock units, vesting in two equal installments on June 2, 2020 and December 2, 2020 (the \"December 2019 Grant\").  On May 28, 2020, the reporting person was granted an additional 82,411 restricted stock units (the \"May 2020 Grant\") and the December 2019 Grant was amended to vest in full, together with the May 2020 Grant, on December 2, 2020.  164,822 shares of common stock were distributed to the Reporting Person on December 17, 2020 following the vesting of the restricted stock units from the December 2019 Grant and the May 2020 Grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 2, 2019, the Reporting Person was granted 82,411 restricted stock units, vesting in two equal installments on June 2, 2020 and December 2, 2020 (the \"December 2019 Grant\").  On May 28, 2020, the reporting person was granted an additional 82,411 restricted stock units (the \"May 2020 Grant\") and the December 2019 Grant was amended to vest in full, together with the May 2020 Grant, on December 2, 2020.  164,822 shares of common stock were distributed to the Reporting Person on December 17, 2020 following the vesting of the restricted stock units from the December 2019 Grant and the May 2020 Grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164822},"source":{"system":"sec-edgar","filing":"0000899243-20-034479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924320034479/doc4.xml","form_type":"4"}},{"id":2937885,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-18T16:15:23.000Z","date":"2020-12-17","kind":"exercise","acquired":true,"shares":164822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":189822,"source":{"system":"sec-edgar","filing":"0000899243-20-034479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924320034479/doc4.xml","form_type":"4"}},{"id":2937884,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-18T16:15:23.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":68550,"price":1.36,"value":93228.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units"}],"balance_after":121272,"source":{"system":"sec-edgar","filing":"0000899243-20-034479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924320034479/doc4.xml","form_type":"4"}},{"id":3130646,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-29T17:56:17.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":82411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% shall vest on December 2, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% shall vest on December 2, 2020."}],"balance_after":82411,"derivative":{"underlying":"Common Stock","underlying_shares":82411},"source":{"system":"sec-edgar","filing":"0000899243-20-014585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924320014585/doc4.xml","form_type":"4"}},{"id":3130645,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-29T17:56:17.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":82411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This restricted stock unit award was previously reported on a Form 4 filed on 12/4/2019. In connection with the new award also reported on this Form 4, this award was amended on May 28, 2020 such that it will now vest in full on December 2, 2020 rather than in two installments.  The new award and the amended award are intended to provide additional retentive value to the recipient."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% shall vest on December 2, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% shall vest on December 2, 2020."}],"balance_after":82411,"derivative":{"underlying":"Common Stock","underlying_shares":82411},"source":{"system":"sec-edgar","filing":"0000899243-20-014585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924320014585/doc4.xml","form_type":"4"}},{"id":3352593,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-04T21:28:34.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares vest in 48 equal monthly installments beginning January 2, 2020."}],"balance_after":153000,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-01","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0000899243-19-028520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924319028520/doc4.xml","form_type":"4"}},{"id":3352592,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-04T21:28:34.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":82411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% shall vest on June 2, 2020 and the remaining 50% shall vest on December 2, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% shall vest on June 2, 2020 and the remaining 50% shall vest on December 2, 2020."}],"balance_after":82411,"derivative":{"underlying":"Common Stock","underlying_shares":82411},"source":{"system":"sec-edgar","filing":"0000899243-19-028520","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924319028520/doc4.xml","form_type":"4"}},{"id":3619081,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T19:56:30.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option shall vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of February 19, 2019."}],"balance_after":125000,"derivative":{"exercise_price":6.7,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-19-005943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000089924319005943/doc4.xml","form_type":"4"}},{"id":3939027,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-10T11:27:27.000Z","date":"2018-05-09","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on June 20, 2017 and the remaining shares vest in 36 equal monthly installments thereafter"}],"balance_after":167031,"derivative":{"exercise_price":1.59,"expiration_date":"2026-09-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-029082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919118029082/doc4.xml","form_type":"4"}},{"id":3939026,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-10T11:27:27.000Z","date":"2018-05-09","kind":"exercise","acquired":true,"shares":25000,"price":1.59,"value":39750.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-18-029082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919118029082/doc4.xml","form_type":"4"}},{"id":4066232,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":34293,"kind":"person","name":"WHOLIHAN EDWARD","position":1,"cik":"0001719764","reported_name":"WHOLIHAN EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T16:13:49.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares vest in 48 equal monthly installments beginning March 9, 2018"}],"balance_after":75000,"derivative":{"exercise_price":6.91,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-009174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919118009174/doc4.xml","form_type":"4"}}]}